HomeFileStructural heart disease

Structural heart disease

View Category

Structural heart disease

Which Low-Flow, Low-Gradient Patients Benefit from Valve Replacement?

A mean gradient ≥40 mmHg, an aortic valve area ≤1 cm², or a combination of both, during dobutamine stress...
solaci -
Learn More
Other

ACC 2018 | Flu Vaccination Reduces Mortality in Heart Failure Hospitalizations

Heart failure patients vaccinated against influenza are at a significantly lower risk of dying, both during flu...
solaci -
Learn More
Structural heart disease

Reverse Myocardial Remodeling Following Valve Replacement

After aortic valve replacement, focal fibrosis does not resolve, but diffuse fibrosis and cell hypertrophy regress. As...
solaci -
Learn More
Other

ACC 2018 | Echocardiographic Data Help Better Choose Patients for Patent Foramen Ovale Closure

A new randomized controlled trial of patients who underwent patent foramen ovale (PFO) closure in cryptogenic stroke...
solaci -
Learn More
Structural heart disease

NOTION: 5-Year Outcomes of TAVR vs. Surgery in Low-Risk Patients are Promising

At 5 years, there were no differences in all-cause death, stroke, acute myocardial infarction, or all of these...
solaci -
Learn More
Structural heart disease

Permanent Pacemaker: still TAVR’s Aquila’s Heel

TAVR has shown benefits in high risk patients (prohibitive) and in intermediate risk patients, but the need for permanent...
solaci -
Learn More
Structural heart disease

Next-Day Discharge after TAVR: Is It Viable?

Next-day discharge after transfemoral transcatheter aortic valve replacement (TAVR) might be viable, with no major complications at 30 days...
solaci -
Learn More
Coronary disease

Keys to Productivity Improvement in the Cath Lab

The systematic reduction of inefficiencies in the catheterization laboratory (such as the improvement of lab room start...
solaci -
Learn More